Evidence map›Paper›PMID 30934533›Full record

ReviewInternational journal of molecular sciences2019

Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis.

Andreina Baj, Elisabetta Moro, Michela Bistoletti, Viviana Orlandi, Francesca Crema, Cristina Giaroni

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 4 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 4 syntheses or guidelines pooled it, 324 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andreina BajDepartment of Medicine and Surgery, University of Insubria, via H Dunant 5, 21100 Varese, Italy. andreina.baj@uninsubria.it.ORCID 0000-0003-0088-2712
Elisabetta MoroDepartment of Internal Medicine and Therapeutics, Section of Pharmacology, University of Pavia, via Ferrata 9, 27100 Pavia, Italy. elisabetta.moro@unipv.it.
Michela BistolettiDepartment of Medicine and Surgery, University of Insubria, via H Dunant 5, 21100 Varese, Italy. m.bistoletti1@uninsubria.it.
Viviana OrlandiDepartment of Biotechnology and Life Sciences, University of Insubria, via H Dunant 5, 21100 Varese, Italy. viviana.orlandi@unisubria.it.
Francesca CremaDepartment of Internal Medicine and Therapeutics, Section of Pharmacology, University of Pavia, via Ferrata 9, 27100 Pavia, Italy. francesca.crema@unipv.it.
Cristina GiaroniDepartment of Medicine and Surgery, University of Insubria, via H Dunant 5, 21100 Varese, Italy. cristina.giaroni@uninsubria.it.ORCID 0000-0002-3760-3441
University of Insubria · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A complex bidirectional communication system exists between the gastrointestinal tract and the brain. Initially termed the "gut-brain axis" it is now renamed the "microbiota-gut-brain axis" considering the pivotal role of gut microbiota in maintaining local and systemic homeostasis. Different cellular and molecular pathways act along this axis and strong attention is paid to neuroactive molecules (neurotransmitters, i.e., noradrenaline, dopamine, serotonin, gamma aminobutyric acid and glutamate and metabolites, i.e., tryptophan metabolites), sustaining a possible interkingdom communication system between eukaryota and prokaryota. This review provides a description of the most up-to-date evidence on glutamate as a neurotransmitter/neuromodulator in this bidirectional communication axis. Modulation of glutamatergic receptor activity along the microbiota-gut-brain axis may influence gut (i.e., taste, visceral sensitivity and motility) and brain functions (stress response, mood and behavior) and alterations of glutamatergic transmission may participate to the pathogenesis of local and brain disorders. In this latter context, we will focus on two major gut disorders, such as irritable bowel syndrome and inflammatory bowel disease, both characterized by psychiatric co-morbidity. Research in this area opens the possibility to target glutamatergic neurotransmission, either pharmacologically or by the use of probiotics producing neuroactive molecules, as a therapeutic approach for the treatment of gastrointestinal and related psychiatric disorders.

Indexed as

Gastrointestinal MicrobiomeSignal TransductionAnimalsBrainGastrointestinal TractGlutamic AcidHumansNeurotransmitter AgentsGlutamic AcidNeurotransmitter Agentsdysbiosisglutamateglutamate receptorsinflammatory bowel disease (IBD)irritable bowel syndrome (IBS)microbiota-gut-brain axis

Identifiers

PMID30934533
PMCPMC6471396
OpenAlexW2922938215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.